Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MaReNa Diagnostic and Consulting Center appears to be an Israel-based specialty medical practice focused on forensic and diagnostic neuropsychiatry rather than a drug-development biotech company. Public references associate the organization with Dr. Ilya Reznik, who is described as a board-certified specialist in adult forensic and clinical neuropsychiatry and as the center's chief physician or medical director. The entity is also linked to the registered name M.R.N.A Medical Institute for Forensic & Diagnostic Neuropsychiatry Ltd. Its activities appear to center on neuropsychiatric evaluation, clinical consulting, and specialist medical services, with public mentions in the context of expertise related to medicinal cannabis and neuropsychiatric conditions. No evidence was found of a proprietary therapeutic pipeline, investigational drug assets, or biopharma partnering activity typical of biotech or pharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MaReNa Diagnostic and Consulting Center.